Zylox-Tonbridge Medical Statements
21
Data from Zylox-Tonbridge Medical`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
CNY - Chinese yuan
Last reporting period:
30 Jun, 2023
Next reporting period:
27 Dec, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Zylox-Tonbridge Medical Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
230.13
26.9 %
100
59.485
25.8
170.65
24.4 %
74.2
124.24
54
121.95
53
252.77
-10.7 %
109.8
-82.125
43.7 %
-35.7
46.909
20.4
—
0
-35.223
60 %
-15.3
0.291
0.1
-35.514
59.7 %
-15.4
-0.108
329.68
181.35
18.7 %
100
44.155
24.3
137.19
18.8 %
75.7
136.86
75.5
143.58
79.2
283.08
46.6 %
156.1
-145.89
-88 %
-80.4
67.164
37
—
0
-88.051
-245.2 %
-48.6
—
0
-88.051
-245.2 %
-48.6
-0.267
329.78
152.74
43.5 %
100
37.266
24.4
115.48
44.8 %
75.6
90.616
59.3
99.801
65.3
193.07
-12.9 %
126.4
-77.597
45.3 %
-50.8
52.112
34.1
—
0
-25.504
80.4 %
-16.7
—
0
-25.504
80.4 %
-16.7
-0.077
330.99
106.43
48.9 %
100
26.671
25.1
79.757
53 %
74.9
116.04
109
114.2
107.3
221.59
72.5 %
208.2
-141.83
-85.9 %
-133.3
11.858
11.1
—
0
-129.97
-86.4 %
-122.1
—
0
-129.97
-86.4 %
-122.1
-0.506
256.79
71.484
—
100
19.36
27.1
52.124
—
72.9
46.35
64.8
79.08
110.6
128.43
—
179.7
-76.31
—
-106.8
6.602
9.2
—
0
-69.717
—
-97.5
—
0
-69.717
—
-97.5
-0.21
332.4